Background {#Sec1}
==========

Probiotics are live organism that, when administered in adequate amounts, confer a health benefit on the host \[[@CR1]\]. They exert their beneficial effect via a wide array of mechanisms including direct and indirect antagonism with enteropathogens, improvement of the intestinal barrier function and activation of the mucosal immune system \[[@CR2], [@CR3]\]. Direct antagonism with enteropathogens is mediated via production of antimicrobial compounds such as organic acids and bacteriocins, competition for nutrients and minerals, and occupation of adhesion sites \[[@CR2]\]. Bifidobacteria and lactobacilli are important constituents of the human gut microbiota and have been associated with a good health status of the host \[[@CR3], [@CR4]\]. They are the two major genera used for probiotic applications and have a long history of safe use. Specific strains from bifidobacteria and lactobacilli have been shown to protect against pathogens, with strain specific effects \[[@CR4]\].

*Bifidobacterium thermophilum* is a relatively oxygen tolerant *Bifidobacterium* species that has been isolated from bovine rumen, sewage, and from piglet, calf and baby feces \[[@CR5], [@CR6]\]. Peptidoglycans from *B. thermophilum* strain P2-91 protect mice against *Escherichia coli* infections and improve cytotoxic activity of mice lymphocytes \[[@CR7], [@CR8]\]. Furthermore, chicken were more resistant to *E. coli* infection after oral administration of *B. thermophilum* \[[@CR9]\]. The infant feces isolate *B. thermophilum* RBL67 (RBL67) is a promising probiotic candidate which genome was sequenced \[[@CR10]\]. The strain can grow under low oxygen, at pHs as low as 4.0 and at temperatures up to 47 °C. Further, it can reach high cell yield numbers in fermentation which makes it suitable to be applied in industrial fermentations \[[@CR6], [@CR11]--[@CR14]\]. Furthermore, RBL67 decreases *S.* Typhimurium counts in an in vitro fermentation model of the gastrointestinal tract \[[@CR14]\], reduces severity of rotavirus-associated diarrhea in suckling mice \[[@CR15]\], and blocks invasion of *S.* Typhimurium and *L. monocytogenes* to human intestinal cell lines \[[@CR13], [@CR16]\]. However, the underlying mechanisms of RBL67-*Salmonella* interaction are not elucidated yet.

*Salmonella* species are a major cause of food-borne diseases with an estimated world-wide annual infection rate of 93.8 million cases and 155,000 deaths \[[@CR17]\]. *Salmonella* usually infect humans after ingestion of contaminated food products \[[@CR18], [@CR19]\]. *Salmonella enterica* subsp. *enterica* serovar Typhimurium (*S.* Typhimurium) is a *Salmonella* serotype frequently encountered in clinical cases \[[@CR18]\]. Its pathogenesis depends on multiple factors including motility and chemotaxis, adhesion, invasion and persistence. The majority of relevant virulence determinants are located on *Salmonella* pathogenicity islands (SPIs) and are regulated by a complex molecular network that transmits environmental signals of conditions prevailing in the host \[[@CR18]\]. *Salmonella* invasion is dependent on the gut environment and is enhanced by low oxygen tension, high osmolarity, neutral pH and acetate, whereas cationic peptides, bile, propionate and butyrate suppress invasion \[[@CR18], [@CR20]\]. One of the key regulators for *Salmonella* invasion is HilA \[[@CR21]\]. HilA expression is affected by environmental signals and enables *Salmonella* to express different invasive phenotypes under different conditions \[[@CR18], [@CR22], [@CR23]\]. Modulation of the gut environment via pre- and/or probiotic treatments may alter the gene expression of pathogens like *Salmonella*, either indirectly via production of organic acids or directly via microbe-microbe interactions \[[@CR2]\]. Indeed, probiotic strains were reported to modulate the transcriptional response of *Salmonella*. PhoP, a postulated repressor of *hil*A expression was activated and HilA was repressed during growth in the presence of supernatant of *Lactobacillus rhamnosus* GG \[[@CR23]\]. However, information about modulation of gene expression in enteropathogens due to direct microbe-microbe interaction is still scarce and unraveling the transcriptomic response of these multifactorial interactions is challenging.

RNA-sequencing (RNA-seq) is a powerful tool to determine the transcriptional response of an organism in a complex culture because interference of signals from other organisms is limited \[[@CR24]\]. In this study we investigated the potential of *B. thermophilum* RBL67 to modulate the transcriptome of *S.* Typhimurium N-15. The response of RBL67 and *Salmonella* Typhimurium N-15 in the co-culture was compared to mono-cultures using RNA-seq in attempt to provide insight in the protective mechanism of RBL67 against *Salmonella* infections.

Methods {#Sec2}
=======

Bacterial strains {#Sec3}
-----------------

*Salmonella* Typhimurium N-15 was isolated from a clinical case in Switzerland in 2007 and obtained from the National Reference Centre for Enteropathogenic Bacteria and Listeria (NENT; Zurich, Switzerland). *Bifidobacterium thermophilum* RBL67 (=LMG S-23614), originally isolated from infant feces \[[@CR6]\], was obtained from our own culture collection.

Batch fermentation conditions {#Sec4}
-----------------------------

Two sets of fermentations were performed, each set consisting of six fermentations. The first set was composed of three RBL67 mono-cultures and three RBL67-N-15 co-cultures. The second set consisted of three N-15 mono-cultures and another set of three RBL67-N-15co-cultures. The first set of three co-cultures was used for sampling RBL67-RNA at *t* = 5 h and the second for sampling N15-RNA at *t* = 4 h. Bacteria were cultured in 350 mL scale Sixfors bioreactors (Infors AG, Bottmingen, Switzerland) using 310 mL YCFA medium \[[@CR25]\] supplemented with 6 g/L glucose (Sigma-Aldrich Chemie GmbH, Buchs, Switzerland). Fermentations were performed at 38 °C with stirring at 200 rpm for 24 h. A constant pH of 6.0 was maintained by automated addition of 2.5 M NaOH. Anaerobic conditions were ensured by purging the headspace with CO~2~. Fermentations were inoculated with 4 % (*v*/*v*) of a 16 h grown pre-culture. Pre-cultures were prepared by propagating strains twice in 10 mL YCFA medium in Hungate tubes to adapt the strains to the medium and anaerobic conditions. The pre-cultures were centrifuged (6000 × g, 5 min), washed in 0.1 % peptone water reduced with 0.05 % L-cysteine hydrochloride (VWR International AG, Dietikon, Switzerland) and resuspended in 2 mL peptone water before inoculation to the fermenter.

Growth was monitored by optical density measurements at 600 nm (OD~600~) using a Biochrom WPA CO8000 cell density meter (Biochrom, Cambridge, United Kingdom). Samples were taken hourly until the stationary growth phase was reached, with a final sample taken after 24 h. Metabolite and sugar concentrations were determined by HPLC analysis (Thermo Fisher Scientific, Wohlen, Switzerland) as described previously \[[@CR26]\]. Carbon balance as % of carbons recovered was calculated on the basis of consumed glucose and produced organic acids. Viable cell counts of RBL67 were determined by plating appropriate dilutions on MRS agar (Biolife, Milan, Italy), supplemented with 0.05 % L-cysteine hydrochloride (MRS-C). Viable cell counts of N-15 were determined on MacConkey Agar No. 2 (Oxoid AG, Pratteln, Switzerland). Co-culture effluent samples were plated on MRS-C agar supplemented with 5 g L^−1^ mupirocin (VWR International AG, Dietikon, Switzerland) to select for RBL67 \[[@CR27]\], and on MacConkey Agar No. 2 to select for N-15. MRS plates were incubated anaerobically using anaerobic gas pack systems (AnaeroGen TM, Oxoid AG) at 37 °C for 48 h. MacConkey Agar plates were incubated aerobically at 37 °C for 24 h.

Maximum specific growth rates were calculated for each replication separately (*N* = 3) from the slope of the curve of the log cell counts versus time during the exponential growth phase.

Sampling for RNA extraction {#Sec5}
---------------------------

RBL67 and N-15 mono- and co-culture samples were subjected to different procedures to allow optimal RNA extraction of both RBL67 and N-15.

Mono- and co-culture samples of N-15 cultures (20 mL each) were directly transferred to 20 mL 60 % glycerol (Sigma-Aldrich Chemie GmbH, Buchs, Switzerland) at −40 °C, kept on ice for 20 min and centrifuged for 15 min (3220 × g, 4 °C). The supernatant was discarded and the resulting pellets were immediately frozen at −80 °C until RNA extraction. Mono- and co-culture samples of RBL67 cultures were shortly centrifuged (10,000 × g, 20 s). The RBL67 mono-culture pellets were resuspended in 400 μl MRS-C and transferred to a pre-chilled screw cap tube, containing 500 mg glass beads (0.1 mm; Biospec Products Inc., Bartlesville, USA), 500 μl chloroform/phenol (1:1, *v*/*v*), 30 μl 3 M Na-acetate (pH 5.2) and 30 μl SDS 10 % \[[@CR28]\]. The pellets of the RBL67 co-culture were resuspended in 12 mL of RNAprotect® Bacteria Reagent (Qiagen AG, Basel, Switzerland), incubated for 5 min at room temperature and centrifuged again (10,000 × g, 20 s). Both samples were then rapidly frozen in liquid nitrogen and stored at −80 °C until RNA extraction.

RNA-extraction and ribosomal RNA depletion {#Sec6}
------------------------------------------

Frozen pellets from N-15 samples were resuspended in 200 μl 10 mM Tris-buffer (pH 8.0). Total RNA was extracted using the High Pure RNA isolation kit (Roche Diagnostics, Rotkreuz, Switzerland), according to the manufacturer's instructions. Total RNA of RBL67 mono- and co-culture samples was extracted using a phenol/chloroform extraction method \[[@CR28]\], followed by a purification using the High Pure RNA isolation kit (Roche Diagnostics). Prior to RNA extraction the sample from the RBL67 co-culture was resuspended in MRS-C medium and transferred to a pre-chilled mix of 500 mg glass beads (Biospec Products Inc.) and TRI Reagent® (Life Technologies Europe BV, Zug, Switzerland).

RNA quantity and purity was determined on a NanoDrop 1000 Spectrophotometer (Thermo Fisher Scientific, Washington, USA) and RNA integrity was tested with an Agilent 2100 Bioanalyzer (Agilent, Basel, Switzerland). RBL67 samples with a RNA integrity number (RIN) ≥ 9.5 and a 16S/23S-rRNA ratio ≥1.6 were used for ribosomal RNA depletion and subsequent RNA-sequencing. Due to the aberrant nature of ribosomal RNA of *S.* Typhimurium \[[@CR29]\], the RIN value and the 16S/23S-rRNA ratio could not be calculated for N-15. Hence we selected samples which were comparable to the profiles reported previously for *Salmonella* \[[@CR30]\], i.e. a straight zero line (indicating no RNA degradation), absence of 23S RNA and appearance of two additional peaks neighboring the 16S peak.

Depletion of ribosomal RNA from 10 μg total RNA was performed using the MICROBExpress™ Bacterial mRNA Enrichment Kit (Life Technologies Europe BV, Zug, Switzerland) according to the manufacturer's instructions. Additionally, EDTA (1 mM) was added to chelate divalent cations present in the RNA solution.

RNA-sequencing {#Sec7}
--------------

RNA-sequencing was performed on an Illumina HiSeq 2000 sequencer (Illumina Inc., California, USA) at the Functional Genomics Center Zurich (FGCZ). Libraries were prepared using the TruSeq Stranded mRNA Sample Prep Kit (Illumina) according to the manufacturer's protocol. The libraries were qualitatively and quantitatively checked using a Qubit® (1.0) Fluorometer (Life Technologies Europe BV, Zug, Switzerland) and a Bioanalyzer 2100 (Agilent, Basel, Switzerland) and were subsequently normalized at 10 nM in Tris-Cl (10 mM, pH 8.5) containing 0.1 % Tween20. Cluster generation was performed using the TruSeq SR Cluster Kit v3-cBot-HS (Illumina) using 8 pM of pooled normalized libraries on the cBOT and stranded sequencing of 100 bp was done using the TruSeq SBS Kit v3-HS (Illumina). Each set of samples (*N* = 6) was analyzed in a separate sequencing lane.

RNA-Seq data analysis {#Sec8}
---------------------

Illumina raw data reads (100 bp) were separated by barcode and mapped against the genome of RBL67 (GenBank accession no. CP004346) or *Salmonella* Typhimurium LT2 (GenBank accession no. AE006468) using the CLC Genomics Workbench 6.5.1 (CLCbio, Aarhus, Denmark) applying the default settings. Maximum allowance of mismatches was set at 2, minimum length fraction at 0.9 and minimum similarity fraction at 0.8.

Statistical analysis for differential gene expression of the mono- and co-cultures was done with the statistical software R ([http://www.R-project.org](http://www.r-project.org/)) using the GLM method \[[@CR31]\] included in the Bioconductor EdgeR software package \[[@CR32]--[@CR34]\] based on negative binomial distribution. Genes with low read numbers (sum of reads in all samples \<3 counts per million (cpm)) or with high read numbers (number of reads \>50,000 cpm in each sample) were filtered out before data normalization. A false discovery rate (FDR) value \<0.05 and a differential expression of at least 2 fold (1 \< log~2~ ratio \< −1) was used as cut off for significant differentially expressed genes in mono-culture and co-culture \[[@CR35]\]. Proteins of RBL67 and LT2 were assigned to gene ontology categories (GO) using Blast2GO at standard settings \[[@CR36]\]. GO categories enrichment analyses were performed and visualized using the BiNGO plugin \[[@CR37]\] in Cytoscape (v.3.0.1, \[[@CR38]\]) applying the hypergeometric test with Benjamini and Hochberg false discovery rate correction option. The significance cutoff for overrepresented gene ontology categories was a corrected *p*-value of \<0.05.

Virulence factors of *Salmonella* LT2 were identified by genome wide blast against the virulence factor database (VFDB) \[[@CR39]\], using a cut off E-value of 1^−20^. Significant enrichment of virulence factors was calculated using the Fisher's Exact Test Calculator for 2 × 2 Contingency at [www.research.microsoft.com/en-us/um/redmond/projects/mscompbio/fisherexacttest/](http://www.research.microsoft.com/en-us/um/redmond/projects/mscompbio/fisherexacttest/).

The RNAseq data discussed in this publication have been deposited in NCBI's Gene Expression Omnibus \[[@CR40]\] and are accessible through GEO Series accession number GSE65716 (<http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE65716>).

Statistical analysis {#Sec9}
--------------------

Statistical analysis for cell counts (log~10~ transformation) and growth rates were performed using JMP 10.0 (SAS Institute., Cary, NC). Cell counts and maximum specific growth rates of mono-and co-cultures were tested for significant differences using the non-parametric Kruskal-Wallis (*P*-value \<0.05).

Results {#Sec10}
=======

Growth characteristics of RBL67 in mono- and co-culture with N-15 {#Sec11}
-----------------------------------------------------------------

To analyze interactions between *B. thermophilum* RBL67 and *Salmonella* N-15, both strains were grown in pH controlled mono- and co-cultures (pH 6.0) and growth characteristics were compared. The maximum specific growth rate of RBL67 in mono-culture (μ~max~ = 0.26 ± 0.05 h^−1^) was significantly lower compared to that in co-culture (μ~max~ = 0.33 ± 0.01 h^−1^). The stationary growth phase was reached after approximately 8 h in both cultures, with final cell counts of 8.88 ± 0.10 log~10~ cfu mL^−1^ and 9.12 ± 0.14 log~10~ cfu mL^−1^ in the mono- and co-culture, respectively (Fig. [1a](#Fig1){ref-type="fig"}).Fig. 1Cell counts and metabolic profiles of RBL67 in mono-culture and in co-cultures with N-15. **a** Cell counts in mono- (*open symbols*) and co-culture (*closed symbols*). **b** Metabolite concentration in mono- (*open symbols*) and co-culture (*closed symbols*). Means ± SD from three biological replicates are presented. \*Cell counts significantly different between mono- and co-culture with the non-parametric Kruskal-Wallis Test (*P* \< 0.05); *square*: glucose; *circle*: acetate; *triangle*: lactate and *diamonds*: formate

Glucose consumption and metabolite profiles were similar for RBL67 in mono- and co-culture (Fig. [1b](#Fig1){ref-type="fig"}). In both cultures, glucose was depleted after 8 h which corresponded to the onset of the stationary growth phase, indicating growth limitation by the carbon source. The main metabolites produced in mono-cultures were 50 ± 3 mM acetate, 15 ± 1 mM lactate, and 9 ± 0.3 mM formate after 8 h, corresponding to a calculated carbon recovery of 103 %. A slightly lower acetate concentration was observed in co-culture: 45 ± 2 mM acetate. Further, 16 ± 2 mM lactate and 7 ± 2 mM formate were produced after 8 h, corresponding to a carbon recovery of 100 %.

Taken together, RBL67 growth was slightly enhanced in the co-culture with *Salmonella* compared to mono-culture and only small differences in organic acid production were observed.

Global transcriptional response of RBL67 to co-culture with N-15 {#Sec12}
----------------------------------------------------------------

To elucidate the response of RBL67 to N-15 on a global level, the transcriptome profiles of *B. thermophilum* RBL67 grown in mono- and in co-culture were compared. Samples were taken after 5 h of growth, a time point at which RBL67 displayed exponential growth in both cultures (Fig. [1](#Fig1){ref-type="fig"}). Viable RBL67 cell counts at harvesting point were 8.07 ± 0.07 and 8.53 ± 0.04 log~10~ cfu mL^−1,^ in the mono- and in co-culture, respectively. RNA sequencing of RBL67 cultures resulted in a mean read number of 37,365,651 and 31,752,403 for mono- and co-cultures, respectively. Thereof, 93 % of the reads deriving from the mono-cultures and 79 % of the reads from the co-cultures could be mapped onto the RBL67 genome. Differential gene expression analysis revealed 57 genes being significantly differentially expressed in mono- compared to co-cultures (Tables [1](#Tab1){ref-type="table"} and [2](#Tab2){ref-type="table"}). An operon involved in lipid export (D805_0155-D805_0157), sugar transport (D805_1600-D805_1602), and an operon of undefined function (D805_1659-D805_1660), together with its putative regulator of the HxlR family (D805_1658) were higher expressed in co- culture (Table [1](#Tab1){ref-type="table"}). Further, a stress response was triggered in co-cultures as revealed by higher expression of the heat shock protein regulator HspR (D805_1678), the SOS-response repressor and protease LexA (D805_0599) and the protease ClpB (D805_1594). The latter gene harbors a HspR-associated inverted repeat (HAIR) in its upstream region and is therefore likely activated by HspR. Additional functions of RBL67 genes higher expressed in co-cultures with *Salmonella* N-15 were related to metal transport (D805_1209) and amino acid metabolism (D805_1238 and D805_1530), including a glutamate-5-kinase (D805_1238) which catalyzes the first step for proline biosynthesis from glutamate.Table 1*Bifidobacterium thermophilum* RBL67 genes higher expressed in co-culture with N-15 compared to mono-cultureLocus tagFunctionlogFC^a^logCPM^b^FDR^c^D805_0058Oligopeptide transport ATP-binding protein OppF (TC 3.A.1.5.1)−1.524.094E-06D805_0077hypothetical protein−1.176.364.8E-07D805_0155Transcriptional regulator, MarR family−1.956.801.2E-17D805_0156hypothetical protein−1.503.640.00401D805_0157Lipid A export ATP-binding/permease protein MsbA−1.178.106.2E-06D805_0382hypothetical protein−1.137.941.4E-06D805_0466FIG 00672402: hypothetical protein−1.007.219.5E-08D805_0503possible conserved integral membrane protein−1.143.080.01355D805_0599SOS-response repressor and protease LexA (EC 3.4.21.88)−1.246.597.9E-09D805_0600hypothetical protein−2.146.182.6E-27D805_0707Inner membrane protein−1.146.163.4E-06D805_1209Zinc ABC transporter, periplasmic-binding protein ZnuA−1.154.691.3E-05D805_1238Cystathionine beta-synthase (EC 4.2.1.22)−1.236.232.7E-09D805_1392putative aminotransferase−1.234.661.2E-05D805_1393hypothetical protein−1.034.300.00118D805_1530Glutamate 5-kinase (EC 2.7.2.11)−1.088.003.9E-09D805_1531COG0536: GTP-binding protein Obg−1.039.162.5E-06D805_1591DNA recombination protein RmuC−1.277.583.6E-12D805_1594ClpB protein−1.068.682.1E-06D805_1600Maltodextrin glucosidase (EC 3.2.1.20)−1.176.235.6E-08D805_1601ABC-type sugar transport system, permease component−1.854.023.9E-09D805_1602MSM (multiple sugar metabolism) operon regulatory protein−1.683.281.1E-05D805_1621Sortase A, LPXTG specific−1.093.520.00557D805_1622hypothetical protein−1.444.425.6E-08D805_1637COG family: predicted phosphohydrolases−1.636.911.8E-21D805_1658Transcriptional regulator, HxlR family−1.074.370.00624D805_1659Rrf2-linked NADH-flavin reductase−2.015.232.9E-14D805_1660COG2110, Macro domain, possibly ADP-ribose binding module−1.834.902.4E-16D805_1678HspR, transcriptional repressor of DnaK operon−1.085.374.9E-08D805_1702transport protein−1.806.583.5E-23^a^ *logFC* log~2~ fold change, ^b^ *logCPM* log~2~ counts per million, ^c^ *FDR* false discovery rateTable 2*Bifidobacterium thermophilum* RBL67 genes higher expressed in mono-culture compared to co-culture with N-15Locus tagFunctionlogFC^a^logCPM^b^FDR^c^D805_0063FIG 00519111: hypothetical protein1.765.671.8E-12D805_0064HTH domain protein2.183.984.1E-09D805_0075hypothetical protein1.045.150.00011D805_0178Ribonucleotide reductase of class Ib (aerobic), alpha subunit (EC 1.17.4.1)1.217.110.04089D805_0341Transcriptional regulator, GntR family domain/Aspartate aminotransferase (EC 2.6.1.1)1.933.720.02045D805_0345Manganese transport protein MntH1.843.710.04055D805_0351Glycosyl transferase, group 2 family protein1.494.480.00041D805_0352Glycosyltransferase (EC:2.4.1.-)1.744.961.3E-07D805_0354glycosyl transferase, group 1 family protein2.074.793.0E-10D805_0355hypothetical protein1.346.144.5E-06D805_0356Glycosyltransferase (EC 2.4.1.-)2.144.961.5E-15D805_0512hypothetical protein2.012.390.03026D805_0524D-lactate dehydrogenase (EC 1.1.1.28)2.853.150.00049D805_0525Aspartate aminotransferase (EC 2.6.1.1)1.913.110.01352D805_0652Oligopeptide transport system permease protein OppC (EC 3.A.1.5.1)2.252.470.00227D805_0656hypothetical protein1.573.010.01267D805_0665hypothetical protein1.185.852.0E-05D805_0693Acetyltransferase, GNAT family2.236.962.7E-31D805_0694hypothetical protein2.803.461.5E-14D805_0698hypothetical protein1.194.020.00369D805_0837putative TraA-like conjugal transfer protein2.753.130.00038D805_0885Ferric iron ABC transporter, iron-binding protein1.632.520.00624D805_0928hypothetical protein1.902.590.00374D805_0948hypothetical protein2.082.960.00118D805_1220hypothetical protein2.603.030.00015D805_1313Methionine ABC transporter permease protein1.522.030.04091D805_1771hypothetical protein1.014.560.01571^a^ *logFC* log~2~ fold change, ^b^ *logCPM* log~2~ counts per million, ^c^ *FDR* false discovery rate

Twenty-seven genes were down regulated in co-cultures compared to monoculture, of which 12 were classified as hypothetical proteins (Table [2](#Tab2){ref-type="table"}). A putative operon encoding glycosyltransferases (ORF D805_0351-D805_0356), three genes involved in amino acid metabolism (D805_0341, D805_0525 and D805_1313), including the glutamate producing enzyme aspartate aminotransferase (EC 2.6.1.1) and two metal transporters (D805_0345 and D805_0885) were higher expressed.

Mapping the co-culture reads to the *Salmonella* Typhimurium LT2 genome resulted in less than 5 million reads mapped (data not shown), indicating that the majority of the RNA isolated form the co-culture after 5 h consisted of bifidobacterial RNA.

Growth characteristics of N-15 in mono- and co-culture with RBL67 {#Sec13}
-----------------------------------------------------------------

In a next step *Salmonella* N-15 was grown in a mono- and co-culture with RBL67, the latter being a repetition of the co-culture presented above. *Salmonella* N-15 had similar maximum specific growth rates of μ~max~ = 0.39 ± 0.02 h^−1^ and 0.38 ± 0.04 h^−1^ in mono- and co-culture, respectively. In the late exponential phase after approximately 5 h of fermentation, the growth rate in the co-culture was smaller compared to mono-culture (Fig. [2a](#Fig2){ref-type="fig"}). The difference in growth resulted in a higher *Salmonella* cell count of 9.10 ± 0.16 log~10~ cfu mL^−1^ in the mono-culture compared to 8.82 ± 0.08 log~10~ cfu mL^−1^ in the co-culture. Glucose was depleted after 10 and 8 h for mono- and co-cultures, respectively (Fig. [2b](#Fig2){ref-type="fig"}). The main metabolites produced by N-15 in mono-culture were 27 ± 0.4 mM acetate, 23 ± 2 mM lactate and 12 ± 2 mM formate, corresponding to a calculated carbon recovery of 93 %. The metabolite production in the co-culture was: 42 ± 4 mM acetate, 17 ± 2 mM lactate and 8 ± 3 mM formate. These values are virtually the same to those from the first co-culture experiments (Fig. [1b](#Fig1){ref-type="fig"}). The calculated carbon mass balance in the co-culture was 99 %.Fig. 2Cell counts and metabolic profiles of N-15 in mono-culture and in co-cultures with RBL67. **a** Cell counts in mono- (*open symbols*) and co-culture (*closed symbols*). **b** Metabolite concentration in mono- (*open symbols*) and co-culture (*closed symbols*). Means ± SD from three biological replicates are presented. \*Cell counts significantly different between mono- and co-culture with the non-parametric Kruskal-Wallis Test (*P* \< 0.05); *square*: glucose; *circle*: acetate; *triangle*: lactate and *diamonds*: formate

*Salmonella* reached slightly lower cell numbers in the co-culture with RBL67 compared to its mono-culture, but was further not affected by the presence of RBL67 concerning growth speed.

Global transcriptional response of N-15 to co-culture with RBL67 {#Sec14}
----------------------------------------------------------------

Because RNA-seq analyses of the co-culture after 5 h growth resulted in low read mapping the transcriptome of N-15 in mono-a-culture and in co-culture with RBL67 was analyzed after 4 h growth. This time-point corresponds to cell counts of 8.42 ± 0.12 and 8.02 ± 0.06 log~10~ cfu mL^−1^ for mono- and co-cultures, respectively. Acetate concentrations at sampling point was 17.8 ± 2.2 mM in the co-culture, slightly higher than the 12.5 ± 1.1 mM in the mono-culture Moreover, at this point *Salmonella* is growing exponentially and at comparable speed in both cultures (Fig. [2b](#Fig2){ref-type="fig"}). From the total mean read numbers of 38,838,013 (mono-culture) and 30,020,491 (co-culture), 91 and 52 % could be mapped onto the genome and plasmid of the sequenced strain *Salmonella* Typhimurium LT2, respectively. In total 701 genes were higher expressed in mono- culture and 1278 genes in the co-culture (Additional file [1](#MOESM1){ref-type="media"}: Tables S1 and S2).

GO category enrichment analysis revealed 88 categories significantly overrepresented in co-culture of which 47 belonged to the cluster "biological processes", 29 to "molecular function" and 29 to "cellular component". Within the cluster biological processes the categories "localization" (GO:051179), "establishment of localization" (GO:051234) and "transport" (GO:006810) were significantly overrepresented (Table [3](#Tab3){ref-type="table"}). Detailed analysis of these categories revealed that they each contained the same 281 genes. At a lower hierarchical level, the category "protein secretion by the type III secretion system" was highly overrepresented (GO:030254, *N* = 49 genes). Further, "siderophore transport" and "carbohydrate transport systems", including "PEP-dependent sugar phosphotransferase systems" (GO:009401, *N* = 33) were overrepresented in co-culture. Other categories overrepresented in biological processes included "multi-organism process" (GO:051704, *N* = 47), "pathogenesis" (GO:009405, *N* = 26) and "interspecies interaction between organisms" (GO:044419, *N* = 35). The majority of the genes (*N* = 26) in the latter category were also found in GO:052049: "interaction with host via protein secreted by type III secretion system". The 26 genes assigned to this category were also present in already mentioned GO:030254: "type III secretion system" category.Table 3Gene Ontology (GO) categories of the *Salmonella* Typhimurium N-15 transcriptome significantly overrepresented in the co-culture with RBL67 compared to mono-cultureGO category*p*-valueN~genes~ in categoryDescription of categoryBiological process GO:0512344.77E-28281establishment of localization GO:0068104.77E-28281transport GO:0511796.29E-25281localization GO:0302548.34E-1542protein secretion by the type III secretion system GO:0517041.80E-1447multi-organism process GO:0517013.20E-1235interaction with host GO:0444193.20E-1235interspecies interaction between organisms GO:0444033.20E-1235symbiosis, encompassing mutualism through parasitism GO:0086438.15E-1152carbohydrate transport GO:0469034.51E-1049secretion GO:0329404.51E-1049secretion by cell GO:0093064.51E-1049protein secretion GO:0520475.68E-1026interaction with other organism via secreted substance involved in symbiotic interaction GO:0520495.68E-1026interaction with host via protein secreted by type III secretion system GO:0520485.68E-1026interaction with host via secreted substance involved in symbiotic interaction GO:0522105.68E-1026interaction with other organism via protein secreted by type III secretion system involved in symbiotic interaction GO:0440465.68E-1026interaction with host via substance released outside of symbiont GO:0516494.63E-0949establishment of localization in cell GO:0516418.25E-0949cellular localization GO:0094059.76E-0826pathogenesis GO:0150312.55E-0649protein transport GO:0451842.55E-0649establishment of protein localization GO:0330362.96E-0650macromolecule localization GO:0081043.67E-0649protein localization GO:0094018.19E-0633phosphoenolpyruvate-dependent sugar phosphotransferase system GO:0070472.10E-0412cellular cell wall organization GO:0452292.10E-0412external encapsulating structure organization GO:0715557.60E-0412cell wall organization GO:0092422.19E-037colanic acid biosynthetic process GO:0521262.19E-037movement in host environment GO:0521922.19E-037movement in environment of other organism involved in symbiotic interaction GO:0444092.19E-037entry into host GO:0463772.19E-037colanic acid metabolic process GO:0518282.19E-037entry into other organism involved in symbiotic interaction GO:0226103.83E-0317biological adhesion GO:0071553.83E-0317cell adhesion GO:0300016.91E-0333metal ion transport GO:0068148.26E-0316sodium ion transport GO:0092351.23E-0214cobalamin metabolic process GO:0092361.23E-0214cobalamin biosynthetic process GO:0158912.34E-025siderophore transport GO:0191842.34E-025nonribosomal peptide biosynthetic process GO:0068112.34E-0247ion transport GO:0156722.61E-0227monovalent inorganic cation transport GO:0068123.45E-0237cation transport GO:0067784.86E-0216porphyrin metabolic process GO:0067794.86E-0216porphyrin biosynthetic processMolecular function GO:0052154.79E-20215transporter activity GO:0151441.57E-0939carbohydrate transmembrane transporter activity GO:0228921.31E-08111substrate-specific transporter activity GO:0228919.42E-0899substrate-specific transmembrane transporter activity GO:0511199.81E-0834sugar transmembrane transporter activity GO:0228571.61E-07107transmembrane transporter activity GO:0083241.82E-0764cation transmembrane transporter activity GO:0054021.79E-0629cation:sugar symporter activity GO:0150755.82E-0670ion transmembrane transporter activity GO:0152916.89E-0644secondary active transmembrane transporter activity GO:0152946.89E-0634solute:cation symporter activity GO:0152936.89E-0634symporter activity GO:0152956.89E-0627solute:hydrogen symporter activity GO:0053516.89E-0627sugar:hydrogen symporter activity GO:0228045.84E-0571active transmembrane transporter activity GO:0150826.07E-0313di-, tri-valent inorganic cation transmembrane transporter activity GO:0468737.20E-0323metal ion transmembrane transporter activity GO:0228909.53E-0328inorganic cation transmembrane transporter activity GO:0151491.06E-028hexose transmembrane transporter activity GO:0151451.06E-028monosaccharide transmembrane transporter activity GO:0153432.20E-025siderophore-iron transmembrane transporter activity GO:0429272.20E-025siderophore transporter activity GO:0053812.59E-028iron ion transmembrane transporter activity GO:0469152.59E-0211transition metal ion transmembrane transporter activity GO:0428792.59E-026aldonate transmembrane transporter activity GO:0151282.59E-026gluconate transmembrane transporter activity GO:0055063.93E-0216iron ion binding GO:0469434.82E-0226carboxylic acid transmembrane transporter activity GO:0053424.82E-0226organic acid transmembrane transporter activityCellular component GO:0160206.15E-12381membrane GO:0302573.05E-1026type III protein secretion system complex GO:0058862.84E-08314plasma membrane GO:0444255.28E-06129membrane part GO:0160215.28E-06124integral to membrane GO:0312245.28E-06124intrinsic to membrane GO:0092794.20E-0547cell outer membrane GO:0198673.67E-0447outer membrane GO:0432344.76E-0450protein complex GO:0092899.12E-0415pilus GO:0444622.45E-03104external encapsulating structure part GO:0431903.32E-024ATP-binding cassette (ABC) transporter complex

In the "molecular function" cluster, "transporter activity" was significantly overrepresented (GO:005215, *N* = 215), with transmembrane transporters being highly abundant (Table [3](#Tab3){ref-type="table"}) The "cellular component" cluster included membrane-associated functions (GO:016020, *N* = 381) including again the overrepresented "type III protein secretion system complex" (GO:030257, *N* = 26) (Table [3](#Tab3){ref-type="table"}). The GO enrichment in the "molecular function" and "cellular component" clusters was similar to that of the "biological processes" cluster.

Summarizing, the transcriptomic analyses of N-15 in co-culture compared to mono-culture revealed responses involved in carbohydrate and metal transport and in extracellular function, mainly secretion of proteins (secretion, cell wall organization, interaction with other organisms).

In the mono-culture, 133 GO categories were significantly enriched of which 101 were assigned to "biological processes", 6 into "molecular functions" and 26 into "cellular components" (Table [4](#Tab4){ref-type="table"}). Overrepresented categories included "cellular process" in the biological processes cluster (GO:009987; *N* = 276) and "structural molecule activity" in the molecular function cluster (GO:005198; *N* = 39). In the cellular components cluster the "intracellular parts" (GO:044424; *N* = 391), which includes the categories "ribosome" (GO:005840; *N* = 33) and "flagellum" (GO:019861; *N* = 19), were overrepresented. GO category 019861 ("flagellum") includes the flagellar biosynthesis encoding operons *flg* and *fli* and *cheZ*. Overall, GO-categories related to flagella and to cell growth like "cellular processes" and "ribosomes" and were significantly overrepresented in the mono-culture transcriptome of *Salmonella* N-15.Table 4Gene Ontology (GO) categories of *Salmonella* Typhimurium N-15 transcriptome significantly overrepresented in the mono-culture compared to co-culture with RBL67GO category*p*-valueN~genes~ in categoryDescription of categoryBiological process GO:0442491.69E-20168cellular biosynthetic process GO:0090582.27E-18174biosynthetic process GO:0104671.16E-1170gene expression GO:0099872.05E-11276cellular process GO:0442371.12E-10236cellular metabolic process GO:0064121.07E-0949translation GO:0442382.26E-08227primary metabolic process GO:0346455.65E-0874cellular macromolecule biosynthetic process GO:0090591.43E-0775macromolecule biosynthetic process GO:0442672.58E-0766cellular protein metabolic process GO:0066331.86E-0612fatty acid biosynthetic process GO:0195384.61E-0682protein metabolic process GO:0442605.80E-06118cellular macromolecule metabolic process GO:0082995.80E-0612isoprenoid biosynthetic process GO:0067205.80E-0612isoprenoid metabolic process GO:0086107.04E-0632lipid biosynthetic process GO:0081521.73E-05286metabolic process GO:0442551.80E-0532cellular lipid metabolic process GO:0431701.93E-05138macromolecule metabolic process GO:0066292.55E-0534lipid metabolic process GO:0066314.06E-0512fatty acid metabolic process GO:0488704.72E-0413cell motility GO:0516744.72E-0413localization of cell GO:0015394.72E-0413ciliary or flagellar motility GO:0442836.74E-0462small molecule biosynthetic process GO:0069288.07E-0413cellular component movement GO:0063509.66E-049transcription GO:0430641.53E-038flagellum organization GO:0091412.48E-0310nucleoside triphosphate metabolic process GO:0160702.77E-0330RNA metabolic process GO:0091083.33E-0317coenzyme biosynthetic process GO:0300303.43E-038cell projection organization GO:0091424.02E-039nucleoside triphosphate biosynthetic process GO:0063515.55E-037transcription, DNA-dependent GO:0400115.89E-0317locomotion GO:0442818.06E-03106small molecule metabolic process GO:0092968.41E-036flagellum assembly GO:0346419.65E-03117cellular nitrogen compound metabolic process GO:0061399.87E-0377nucleobase, nucleoside, nucleotide and nucleic acid metabolic process GO:0327749.87E-037RNA biosynthetic process GO:0197209.87E-037Mo-molybdopterin cofactor metabolic process GO:0323249.87E-037molybdopterin cofactor biosynthetic process GO:0435459.87E-037molybdopterin cofactor metabolic process GO:0511899.87E-037prosthetic group metabolic process GO:0067779.87E-037Mo-molybdopterin cofactor biosynthetic process GO:0160531.01E-0231organic acid biosynthetic process GO:0463941.01E-0231carboxylic acid biosynthetic process GO:0092191.10E-024pyrimidine deoxyribonucleotide metabolic process GO:0093941.10E-0242′-deoxyribonucleotide metabolic process GO:0421801.26E-0258cellular ketone metabolic process GO:0300311.55E-026cell projection assembly GO:0067321.55E-0220coenzyme metabolic process GO:0425591.55E-027pteridine and derivative biosynthetic process GO:0425581.55E-027pteridine and derivative metabolic process GO:0460341.55E-027ATP metabolic process GO:0159851.55E-027energy coupled proton transport, down electrochemical gradient GO:0159861.55E-027ATP synthesis coupled proton transport GO:0061191.55E-027oxidative phosphorylation GO:0067541.55E-027ATP biosynthetic process GO:0442711.65E-0252cellular nitrogen compound biosynthetic process GO:0069501.72E-0226response to stress GO:0226071.93E-0216cellular component assembly GO:0440852.28E-0222cellular component biogenesis GO:0091522.52E-0210purine ribonucleotide biosynthetic process GO:0092012.53E-027ribonucleoside triphosphate biosynthetic process GO:0092062.53E-027purine ribonucleoside triphosphate biosynthetic process GO:0091452.53E-027purine nucleoside triphosphate biosynthetic process GO:0068072.99E-02121nitrogen compound metabolic process GO:0197483.10E-024secondary metabolic process GO:0092343.10E-024menaquinone biosynthetic process GO:0092333.10E-024menaquinone metabolic process GO:0423623.10E-024fat-soluble vitamin biosynthetic process GO:0423713.10E-024vitamin K biosynthetic process GO:0423733.10E-024vitamin K metabolic process GO:0067753.10E-024fat-soluble vitamin metabolic process GO:0091503.10E-0210purine ribonucleotide metabolic process GO:0061643.35E-0211purine nucleotide biosynthetic process GO:0091653.40E-0215nucleotide biosynthetic process GO:0092053.58E-027purine ribonucleoside triphosphate metabolic process GO:0091993.58E-027ribonucleoside triphosphate metabolic process GO:0091443.58E-027purine nucleoside triphosphate metabolic process GO:0197523.59E-0253carboxylic acid metabolic process GO:0434363.59E-0253oxoacid metabolic process GO:0092113.59E-023pyrimidine deoxyribonucleoside triphosphate metabolic process GO:0092003.59E-023deoxyribonucleoside triphosphate metabolic process GO:0091203.59E-023deoxyribonucleoside metabolic process GO:0461253.59E-023pyrimidine deoxyribonucleoside metabolic process GO:0092213.59E-023pyrimidine deoxyribonucleotide biosynthetic process GO:0092633.59E-023deoxyribonucleotide biosynthetic process GO:0092653.59E-0232′-deoxyribonucleotide biosynthetic process GO:0092603.68E-0210ribonucleotide biosynthetic process GO:0061633.85E-0211purine nucleotide metabolic process GO:0194383.88E-0212aromatic compound biosynthetic process GO:0159923.97E-028proton transport GO:0068183.97E-028hydrogen transport GO:0060824.00E-0254organic acid metabolic process GO:0903044.05E-0252nucleic acid metabolic process GO:0436484.38E-029dicarboxylic acid metabolic process GO:0160434.38E-0222cellular component organization GO:0092594.64E-0210ribonucleotide metabolic process GO:0327874.92E-0216monocarboxylic acid metabolic processMolecular function GO:0051982.25E-1039structural molecule activity GO:0037351.05E-0832structural constituent of ribosome GO:0469831.50E-0210protein dimerization activity GO:0037742.16E-0210motor activity GO:0168102.24E-0216hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds GO:0168143.39E-026hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidinesCellular component GO:0444247.14E-22391intracellular part GO:0056228.72E-21395intracellular GO:0057371.19E-16371cytoplasm GO:0432287.58E-1653non-membrane-bounded organelle GO:0432327.58E-1653intracellular non-membrane-bounded organelle GO:0432297.58E-1657intracellular organelle GO:0432267.58E-1657organelle GO:0058401.95E-1033ribosome GO:0305295.54E-1033ribonucleoprotein complex GO:0444441.68E-0941cytoplasmic part GO:0329912.06E-0759macromolecular complex GO:0198611.39E-0619flagellum GO:0092881.47E-0515bacterial-type flagellum GO:0444223.09E-0416organelle part GO:0332799.66E-049ribosomal subunit GO:0164693.31E-038proton-transporting two-sector ATPase complex GO:0429957.19E-0319cell projection GO:0444467.85E-039intracellular organelle part GO:0159348.09E-035large ribosomal subunit GO:0094261.60E-023bacterial-type flagellum basal body, distal rod GO:0094241.60E-023bacterial-type flagellum hook GO:0093171.60E-023acetyl-CoA carboxylase complex GO:0444633.10E-027cell projection part GO:0444613.10E-027bacterial-type flagellum part GO:0444603.10E-027flagellum part GO:0306944.73E-023bacterial-type flagellum basal body, rod

Effect of RBL67 to the virulence response of N-15 {#Sec15}
-------------------------------------------------

GO enrichment analysis revealed enriched differential expression of some virulence genes, such as the 42 genes belonging to "protein secretion by the type III secretion system" (GO:030254) in the co-culture. Therefore we analyzed the regulation of all putative virulence factors of *Salmonella* LT2. A comparison to the virulence database VFDB revealed 151 genes in LT2 putatively involved in virulence \[[@CR39]\]. Of these 151 genes, one was higher expressed in mono-culture, i.e. *phoP* encoding the transcriptional regulator PhoP, a member of the two-component system PhoQ-PhoP. The PhoQ encoding gene was also overexpressed in the mono-culture, although not significant (FDR = 0.063, Additional file [1](#MOESM1){ref-type="media"}: Table S2).

In the co-culture, 122 virulence genes were higher expressed, a significant enrichment of expressed virulence genes (*p* = 7 × 10^−39^ in Fisher's test). The large majority of genes were involved in secretion systems (*N*  = 66) and fimbrial adherence determinants (*N* = 51). The pathogeny island 1 (SPI-1) encodes 39 genes \[[@CR39]\] of which 30 were significantly higher expressed in the co-culture including the complete type III secretion system 1 (TTSS-1) consisting of *sipB*, *sipD*, *prgIHK*, *invACBGH*, *spaSRQPO*, and *sicAP*. Only *avrAI*, *sprB*, *hilC*, *orgC* and *hilD* were not higher expressed in co-culture. Additionally genes located on SPI-2 were higher expressed in co-culture, including the TTSS-2 genes *ssrAB*, s*saBCDE*, s*saGHIJKLMVNOPQRSTU*, *sseAB*, *sseCDE*, *sseFG*, *sscA*, and *sscB*. Further the main activation complex of type 1 fimbriae *fimY*, *fimW* and *fimZ* where higher expressed in co-culture, albeit the latter not significant.

Discussion {#Sec16}
==========

Antagonism and protective effects of selected *B. thermophilum* strains against enterobacteriaceae have been observed in several studies \[[@CR7]--[@CR9], [@CR13], [@CR14]\], but the underlying mechanisms of this antagonism are unknown. In this study we used RNA-sequencing to investigate the global transcriptional response of RBL67 and *Salmonella* N-15 in mono- and co-culture. To our knowledge we present the first study investigating the interaction of a probiotic *Bifidobacterium* strain with enteropathogenic *S.* Typhimurium using RNA-sequencing.

RNA-sequencing was previously shown to be a powerful method to investigate genome-wide transcript analysis in mixed-culture experiments \[[@CR35]\]. In our study we could map at least 10 million reads specifically to one of the genomes, which is clearly above the 5 million reads needed for differential expression analyses in bacterial genomes \[[@CR41]\]. The transcriptome of N-15 mapped to the genome *of Salmonella* Typhimurium LT2 had a similar efficiency as the mapping of the transcriptome of RBL67 to the RBL67 genome, suggesting that mapping reads to a closely related genome is possible. The pathogenicity islands of *Salmonella* Typhimurium strains are conserved and difference in virulence factors contents mainly occurs on plasmid \[[@CR42]\]. We could map RNAseq reads against the plasmid of LT-2, indicating that N-15 has a virulence-genes-encoding plasmid similar to that of LT2. Hence, both strains seem highly similar and the RNAseq data presented resemble closely the transcriptome profile of *Salmonella* Typhimurium strain N-15. Sampling points were chosen when growth speed, cell number and metabolite concentrations were similar in both cultures to allow accurate transcriptomic profiling. Further, fermentations were performed under pH controlled condition to exclude low pH effects.

RBL67 growth was slightly but significantly enhanced in presence of *Salmonella* N-15. Also growth of other *Bifidobacterium* species (*B. globosum*, *B. animalis*, *B. breve*) was shown to be stimulated by *S.* Typhimurium and *S.* Enteriditis, albeit under pH uncontrolled conditions \[[@CR43]\]. A glutamate producing enzyme was repressed and a glutamate consuming enzyme activated in RBL67 in co-culture, suggesting a change in glutamate availability in the presence of N-15. Interestingly, *Salmonella* accumulates glutamate under various conditions \[[@CR44]\] and lysing *Salmonella* cells could provide *B. thermophilum* with additional glutamate resulting in the change in amino acid metabolism and possibly also in the observed growth rate. The elevated expression of 3 stress genes suggests that RBL67 is exposed to weak stress in the presence of *Salmonella* N-15, but the enhanced growth performance indicates that the microbe was able to cope with the stress in the co-culture.

The *Salmonella* N-15 transcriptome was clearly affected by presence of RBL67. Many virulence genes were higher expressed in *Salmonella* N-15 during co-culture with RBL67 and such increased expression may enhance infection rate. However, this would contradict with previous results showing reduced invasion capacity of *Salmonella* to HT29-MTX cells in presence of RBL67 \[[@CR13]\]. *Salmonella* virulence is tightly controlled and the activity of virulence factors at the right time, correct place and in appropriate amounts is crucial for virulence \[[@CR45]\]. Further, environmental factors such as acetate can trigger virulence gene expression in *Salmonella* \[[@CR20]\]. A low concentration of 15 mM acetate at pH 6.7 induces the three invasion determinants *hilA*, *invF* and *sipC* in *S.* Typhimurium and the induction is dependent on acetate kinase (*ackA*) and phosphotransacetylase (*pta*) activity \[[@CR46]\]. The genes *hilA*, and *invF* were higher expressed in co-culture but *ackA* and *pta* were down regulated in co-cultures (Additional file [1](#MOESM1){ref-type="media"}: Table S2) and therefore *hilA* was likely not activated by acetate. The two-component system PhoQ-PhoP was down-regulated in the co-culture. PhoQ-PhoP is a repressor of *hilA*, a key regulator for *Salmonella* invasion \[[@CR18], [@CR21]\] and the higher expression of *hilA* observed in the co-culture seems therefore due to a repressor release mediated by PhoQ-PhoP.

Invasion of *Salmonella* follows sequential expression of first flagellar genes, followed by genes encoded on SPI-1, and eventually type 1 fimbrial genes \[[@CR47]\]. Flagellar genes were repressed while genes of SPI-1 and type 1 fimbriae genes were activated in co-culture compared to mono-culture. This shows that N-15 in co-culture is further progressed in the sequential expression for infection and the balance in virulence gene expression is disturbed by the presence of RBL67. In fact, the expression of SPI-1 and SPI-2 and repression of flagellar genes observed in the co-culture resembles the transcriptional profile of *Salmonella* cells in fibroblast after infection \[[@CR48]\]. Further, an early activation of the type III secretion system-1 (TTSS-1) located on SPI-1 was observed in co-culture. A TTSS-1 expressing *S.* Typhimurium subpopulation is essential for infection, but this subpopulation is also vulnerable to overgrowth by the non-TTSS-1 expressing subpopulation \[[@CR49]\]. An imbalance in the regulation of TTSS-1 results in an inappropriate fraction of TTSS-1 expressing cells and eventually to a decreased infection rate \[[@CR50]\]. This results *in situ* in reduced invasion of human intestinal cells and ultimately eliminates *Salmonella* from the lumen \[[@CR50]\]. In vitro, a reduced infection of human intestinal cells by *Salmonella* in presence of RBL67 and repression of *Salmonella* by RBL67 in a continuous intestinal fermentation model was reported \[[@CR13], [@CR14]\].

Our data provide a first clue on a possible mechanism that could contributes to the antagonistic effects of RBL67 against *Salmonella* spec and other pathogens \[[@CR7]--[@CR9], [@CR13]--[@CR15]\]. The expression of virulence gene at early stage is a burden for the pathogen and may result in lower infection rate and subsequent wash-out from the lumen. In addition, the repression of flagellar genes reduces motility thereby preventing colonization of other areas. Whether the imbalance in virulence gene expression observed in vitro also occurs in situ remains to be elucidated. The effect may be reinforced by simultaneous protection by other probiotic mechanisms such as competition for adhesion sites and nutrients, and acetate production.

Conclusion {#Sec17}
==========

Our study provides first insights into the transcriptome response of *B. thermophilum* RBL67 and *S.* Typhimurium grown in co-cultures under simplified conditions and reveals possible molecular mechanisms of probiotic-pathogen interaction. Our data show that RBL67 has a huge impact on the transcriptome of *Salmonella* and causes in an imbalanced virulence gene expression. This imbalance in the cascade pathway of virulence could represent a novel possible mechanism of how probiotic organisms can protect the host against infections.

Availability of data and materials {#Sec18}
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Data presented in this study are available under NCBI BioProject Record PRJNA274782 accessible through <http://www.ncbi.nlm.nih.gov/bioproject/PRJNA274782>. Gene expression data are directly accessible through GEO Series accession number GSE65716 (<http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE65716>).
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